Details of the Drug
General Information of Drug (ID: DM7GN3E)
Drug Name |
PT-312
|
|||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Synonyms |
Thiourea, N-(5-chloro-2-thiazolyl)-N'-(2-phenylethyl)-; 149486-85-1; PETT Analog 46; PT-312; AC1MHDKX; CHEMBL101348; SCHEMBL6951634; BDBM1879; DTXSID10164309; 1-(5-chlorothiazol-2-yl)-3-phenethyl-thiourea; N-(2-Phenethyl)-N -(2-(5-chlorothiazolyl))thiourea; 1-(5-chloro-1,3-thiazol-2-yl)-3-phenethylthiourea
|
|||||||||||||||||||
Indication |
|
|||||||||||||||||||
Drug Type |
Small molecular drug
|
|||||||||||||||||||
Structure | ||||||||||||||||||||
3D MOL | 2D MOL | |||||||||||||||||||
#Ro5 Violations (Lipinski): 0 | Molecular Weight (mw) | 297.8 | ||||||||||||||||||
Topological Polar Surface Area (xlogp) | 3.8 | |||||||||||||||||||
Rotatable Bond Count (rotbonds) | 4 | |||||||||||||||||||
Hydrogen Bond Donor Count (hbonddonor) | 2 | |||||||||||||||||||
Hydrogen Bond Acceptor Count (hbondacc) | 3 | |||||||||||||||||||
Chemical Identifiers |
|
|||||||||||||||||||
Cross-matching ID | ||||||||||||||||||||
Molecular Interaction Atlas of This Drug
Drug Therapeutic Target (DTT) |
|
||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Molecular Interaction Atlas (MIA) | |||||||||||||||||||||||||||
References